Alto Ingredients (ALTO)
(Delayed Data from NSDQ)
$1.94 USD
+0.05 (2.65%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.95 +0.01 (0.52%) 7:58 PM ET
5-Strong Sell of 5 5
B Value A Growth B Momentum A VGM
Income Statements
Fiscal Year end for Alto Ingredients, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,223 | 1,336 | 1,208 | 897 | 1,425 |
Cost Of Goods | 1,207 | 1,363 | 1,140 | 844 | 1,435 |
Gross Profit | 16 | -28 | 68 | 53 | -10 |
Selling & Adminstrative & Depr. & Amort Expenses | 40 | 34 | 28 | 43 | 65 |
Income After Depreciation & Amortization | -24 | -61 | 40 | 10 | -75 |
Non-Operating Income | 3 | 24 | 11 | -9 | -6 |
Interest Expense | 7 | 2 | 4 | 18 | 20 |
Pretax Income | -28 | -40 | 48 | -17 | -101 |
Income Taxes | 0 | 2 | 1 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | -2 | -12 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -28 | -42 | 46 | -17 | -101 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -28 | -42 | 46 | -15 | -89 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1 | -36 | 64 | 41 | -26 |
Depreciation & Amortization (Cash Flow) | 25 | 25 | 24 | 31 | 49 |
Income After Depreciation & Amortization | -24 | -61 | 40 | 10 | -75 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 73.34 | 71.94 | 72.22 | 58.61 | 47.38 |
Diluted EPS Before Non-Recurring Items | -0.31 | -0.82 | 0.64 | 0.08 | -1.40 |
Diluted Net EPS (GAAP) | -0.40 | -0.60 | 0.61 | -0.28 | -1.90 |
Fiscal Year end for Alto Ingredients, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 273.62 | 318.13 | 317.30 | 313.89 |
Cost Of Goods | NA | 276.15 | 313.97 | 300.12 | 317.06 |
Gross Profit | NA | -2.53 | 4.16 | 17.18 | -3.16 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 14.65 | 8.49 | 7.91 | 8.46 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -17.18 | -4.33 | 9.27 | -11.62 |
Non-Operating Income | NA | 0.45 | 2.84 | 0.06 | 0.02 |
Interest Expense | NA | 2.13 | 2.00 | 1.73 | 1.57 |
Pretax Income | NA | -18.85 | -3.49 | 7.60 | -13.17 |
Income Taxes | NA | 0.10 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -18.95 | -3.49 | 7.60 | -13.17 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -18.95 | -3.49 | 7.60 | -13.17 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 72.97 | 73.19 | 74.10 | 73.82 |
Diluted EPS Before Non-Recurring Items | NA | -0.18 | -0.05 | 0.10 | -0.17 |
Diluted Net EPS (GAAP) | NA | -0.27 | -0.05 | 0.10 | -0.18 |